Next Article in Journal
Characterization of a Botybirnavirus Conferring Hypovirulence in the Phytopathogenic Fungus Botryosphaeria dothidea
Next Article in Special Issue
Protection of Phage Applications in Crop Production: A Patent Landscape
Previous Article in Journal
The Transcriptional Landscape of Marek’s Disease Virus in Primary Chicken B Cells Reveals Novel Splice Variants and Genes
Previous Article in Special Issue
Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant Staphylococcus aureus Infections
Open AccessCommunication

Processing Phage Therapy Requests in a Brussels Military Hospital: Lessons Identified

1
Center for Infectious diseases ID4C, Queen Astrid military hospital, Bruynstraat 1, B-1120 Brussels, Belgium
2
Laboratory for molecular and cellular technology, Queen Astrid military hospital, Bruynstraat 1, B-1120 Brussels, Belgium
*
Author to whom correspondence should be addressed.
Viruses 2019, 11(3), 265; https://doi.org/10.3390/v11030265
Received: 19 February 2019 / Revised: 10 March 2019 / Accepted: 14 March 2019 / Published: 17 March 2019
(This article belongs to the Special Issue Hurdles for Phage Therapy (PT) to Become a Reality)
There is a growing interest in phage therapy as a complementary tool against antimicrobial resistant infections. Since 2007, phages have been used sporadically to treat bacterial infections in well-defined cases in the Queen Astrid military hospital (QAMH) in Brussels, Belgium. In the last two years, external requests for phage therapy have increased significantly. From April 2013 to April 2018, 260 phage therapy requests were addressed to the QAMH. Of these 260 requests, only 15 patients received phage therapy. In this paper, we analyze the phage therapy requests and outcomes in order to improve upon the overall capacity for phage therapy at the QAMH. View Full-Text
Keywords: bacteriophages; phage therapy; antibiotic resistance; Pseudomonas aeruginosa; Escherichia coli; Staphylococcus aureus; Brussels; Belgium bacteriophages; phage therapy; antibiotic resistance; Pseudomonas aeruginosa; Escherichia coli; Staphylococcus aureus; Brussels; Belgium
Show Figures

Figure 1

MDPI and ACS Style

Djebara, S.; Maussen, C.; De Vos, D.; Merabishvili, M.; Damanet, B.; Pang, K.W.; De Leenheer, P.; Strachinaru, I.; Soentjens, P.; Pirnay, J.-P. Processing Phage Therapy Requests in a Brussels Military Hospital: Lessons Identified. Viruses 2019, 11, 265.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop